# TAIWAN-ECMO-CDSS-NEXT - Complete Documentation Inventory

**Analysis Date:** 2025-09-30
**Total Files Analyzed:** 13
**Analysis Status:** ✅ Complete

---

## Executive Summary

This project develops an AI-driven ECMO (Extracorporeal Membrane Oxygenation) Clinical Decision Support System with three integrated components:
- **Navigator**: Bedside risk prediction
- **Planner**: Cost-effectiveness and capacity planning
- **VR Studio**: Team training simulation

---

## 1. SYSTEM ARCHITECTURE

### 1.1 Core Components (13 Total)

#### Data Processing Layer
1. **數據提取器** (Data Extractor)
   - **Tech Stack**: Python, Pandas, SQL
   - **Output**: Standardized cleaned datasets

2. **特徵工程模組** (Feature Engineering Module)
   - **Tech Stack**: Scikit-learn, Feature-engine
   - **Output**: High-quality feature matrices

3. **數據標準化器** (Data Normalizer)
   - **Tech Stack**: StandardScaler, MinMaxScaler
   - **Output**: Consistent data formats

#### Machine Learning Layer
4. **深度學習模型** (Deep Learning Models)
   - **Tech Stack**: TensorFlow, PyTorch
   - **Output**: High-precision prediction models

5. **集成學習器** (Ensemble Learners)
   - **Tech Stack**: XGBoost, RandomForest
   - **Output**: Robust classifiers

6. **時間序列分析器** (Time Series Analyzer)
   - **Tech Stack**: LSTM, ARIMA
   - **Output**: Real-time early warning system

#### System Architecture Layer
7. **API服務層** (API Service Layer)
   - **Tech Stack**: FastAPI, Flask
   - **Output**: RESTful API services

8. **前端界面** (Frontend Interface)
   - **Tech Stack**: React, Vue.js
   - **Output**: User-friendly dashboard

9. **數據庫設計** (Database Design)
   - **Tech Stack**: PostgreSQL, MongoDB
   - **Output**: Efficient data storage

#### Evaluation & Validation Layer
10. **模型評估器** (Model Evaluator)
    - **Tech Stack**: Sklearn.metrics, MLflow
    - **Output**: Model performance reports

11. **臨床驗證框架** (Clinical Validation Framework)
    - **Tech Stack**: Statistical analysis
    - **Output**: Clinical effectiveness evidence

#### Deployment & Monitoring Layer
12. **持續監控系統** (Continuous Monitoring)
    - **Tech Stack**: Prometheus, Grafana
    - **Output**: System stability assurance

### 1.2 Data Sources

#### MIMIC-IV
- **URL**: https://physionet.org/content/mimiciv/
- **Description**: 65,000+ ICU patients with ECMO cases
- **Access**: Permission required
- **Formats**: CSV, PostgreSQL

#### ELSO Registry v3.4
- **URL**: https://www.elso.org/registry.aspx
- **Description**: Global largest ECMO patient database
- **Access**: Research collaboration application
- **Key Variables**: patient_demographics, ecmo_config, outcomes

#### ANZICS
- **URL**: https://www.anzics.org/ecmo-registry/
- **Description**: Australia-New Zealand ECMO database
- **Focus**: Bi-national dataset

---

## 2. DEVELOPMENT PHASES (12 Months)

### Phase 1: Data Collection & Preparation (Months 1-3)
**Tasks:**
- Integrate MIMIC-IV, ELSO databases
- Data cleaning and feature engineering
- ELSO Registry alignment

**Deliverables:**
- Cleaned standardized datasets
- Data analysis report
- `data_dictionary.yaml` (ELSO v3.4 aligned)
- `etl/codes/` (diagnoses, complications, procedures)

---

### Phase 2: Model Development (Months 4-8)
**Tasks:**
- Develop prediction models (survival, complications)
- Build risk stratification algorithms
- Optimize model performance

**Algorithms:**
- Deep Neural Networks
- Gradient Boosting Trees (XGBoost)
- Support Vector Machines
- LSTM/GRU for time series
- CNN-LSTM for early warning

**Deliverables:**
- ECMO survival prediction model (Target AUC: 0.75)
- Complication early warning system
- Risk assessment tools
- Performance evaluation report

**Key Features:**
- age, apache_score, ecmo_type, pre_arrest
- blood_pressure, heart_rate, oxygenation_index, lactate_level
- ecmo flow_rate, duration, type (VA/VV)

**Model Requirements (WP1):**
- Separate VA/VV models
- Class weights for imbalance handling
- Calibration curves
- APACHE-stratified metrics
- Explainability (SHAP, LIME)

---

### Phase 3: Validation & Testing (Months 9-11)
**Tasks:**
- External data validation
- Clinical expert evaluation
- System integration testing

**Validation Protocol:**
- **Retrospective**: Taiwan medical center historical data (n=1000)
- **Prospective Pilot**: 3-month ICU deployment
- **Metrics**: Sensitivity, Specificity, PPV, NPV

**Benchmark Comparisons:**
- APACHE II (AUC: 0.68-0.72)
- SAPS-3 (AUC: 0.66-0.70)
- SAVE score (ECMO-specific)
- RESP score (ECMO-specific)

**Deliverables:**
- Model validation report
- Clinical trial results
- System stability test report

---

### Phase 4: Deployment & Application (Month 12)
**Tasks:**
- Clinical environment deployment
- User training
- Continuous monitoring and improvement

**Deployment Architecture:**

**Frontend:**
- Technology: React/Vue.js
- Features: real-time dashboard, alert system, reporting

**Backend:**
- Technology: Python/FastAPI
- Components: ml_inference, data_pipeline, api_gateway

**Database:**
- Technology: PostgreSQL/MongoDB
- Features: patient_data, model_predictions, audit_logs

**Deliverables:**
- Clinical decision support system
- User manual
- Maintenance protocol

---

## 3. RESEARCH DIRECTIONS (5 Core Areas)

### 3.1 ECMO Survival Prediction
- **Methods**: Deep Neural Networks, Gradient Boosting, SVM
- **Data**: Patient demographics, physiological parameters, treatment history, outcomes
- **Expected Impact**: 5-10% survival improvement, reduced medical risk
- **Target AUC**: 0.75

### 3.2 Complication Early Warning
- **Methods**: Time series anomaly detection, real-time monitoring algorithms
- **Data**: Continuous monitoring data, lab results, imaging
- **Expected Impact**: 15-20% complication reduction, enhanced safety

### 3.3 Treatment Decision Optimization
- **Methods**: Reinforcement learning, multi-objective optimization
- **Data**: Treatment protocols, medication usage, device parameters
- **Expected Impact**: Personalized treatment, reduced medical errors

### 3.4 Resource Allocation Improvement
- **Methods**: Operations research, queuing theory, predictive analytics
- **Data**: Hospital capacity, equipment utilization, staffing, patient flow
- **Expected Impact**: 20-30% resource optimization, cost reduction

### 3.5 Cost-Effectiveness Analysis (WP2)
- **Methods**: Markov models, survival analysis, economic evaluation
- **Data**: Medical costs, length of stay, quality of life, long-term follow-up
- **Outputs**: CER, ICER, CEAC by risk quintile
- **Expected Impact**: Support policy decisions, 10-15% cost reduction

---

## 4. WORK PACKAGES

### WP0: Data Dictionary
**Objective:** Align to ELSO Registry v3.4

**Deliverables:**
- `data_dictionary.yaml` (ELSO-aligned fields)
- `etl/codes/` directory structure
  - diagnoses codes (ICD-10-CM)
  - complications codes
  - procedures codes (ICD-10-PCS, CPT)

**Standards:** ELSO Registry v3.4, SNOMED-CT

---

### WP1: NIRS Model Development
**Objective:** Build explainable NIRS+EHR risk models

**Requirements:**
- Separate VA/VV ECMO models
- Class weights for imbalanced data
- Calibration curves
- APACHE-stratified performance metrics

**Algorithms:**
- RandomForest (baseline)
- XGBoost (ensemble)
- Deep Neural Networks (advanced)

**Features:**
- Clinical: age, apache_score, ecmo_type, pre_arrest, comorbidities
- Physiological: BP, HR, oxygenation index, lactate
- ECMO: type (VA/VV), flow rate, duration
- NIRS: cerebral/somatic oxygen saturation

**Explainability:**
- SHAP values (feature importance)
- LIME (local explanations)
- Attention visualization (DNN)
- Clinical narratives (NLG)

---

### WP2: Cost-Effectiveness Analysis
**Objective:** Economic evaluation by risk stratification

**Methods:**
- Markov cohort models
- Survival analysis (Kaplan-Meier, Cox)
- Probabilistic sensitivity analysis

**Parameters (Taiwan-specific):**
- Local length of stay (LOS)
- Medical costs per day
- Survival rates by risk group
- QALY estimates

**Outputs:**
- CER (Cost-Effectiveness Ratio)
- ICER (Incremental CER)
- CEAC (Cost-Effectiveness Acceptability Curve)
- Analysis by risk quintile (Q1-Q5)

**Dashboard:** Streamlit app (`econ/dashboard.py`)

---

### WP3: VR Training Study
**Objective:** Virtual reality ECMO team training protocol

**Deliverables:**
- VR scenario definitions
  - Cannulation procedures
  - Emergency troubleshooting
  - Complication management
- Study protocol with:
  - Sample size calculation
  - Power analysis (β = 0.80, α = 0.05)
  - Randomization strategy
- Evaluation metrics:
  - Team performance scores
  - Clinical outcome improvements
  - Training effectiveness (pre/post)

**Metrics Document:** `vr-training/metrics.md`
**Protocol:** `vr-training/study_protocol.md`

---

### WP4: SMART on FHIR Integration
**Objective:** EHR-embeddable CDSS application

**Requirements:**
- SMART App Launch (OAuth2)
- FHIR R4 compatibility
- OAuth2 scopes definition:
  - `patient/Observation.read`
  - `patient/Condition.read`
  - `patient/Procedure.read`
  - `patient/MedicationRequest.read`
- EHR embedding documentation

**Standards:**
- SMART on FHIR specification
- FHIR R4 resources
- OAuth 2.0 authorization

**Deliverable:** Minimal working stub with authentication flow

---

### SQL Task: MIMIC-IV ECMO Identification
**Objective:** Extract ECMO episodes from MIMIC-IV Demo

**Files:**
- `sql/mimic_ecmo_itemids.sql` (identify ECMO item IDs)
- `sql/identify_ecmo.sql` (extract episodes)

**Database:** MIMIC-IV Demo (PhysioNet)

**Output:** ECMO episode table with:
- subject_id, hadm_id, stay_id
- ecmo_start_time, ecmo_end_time
- ecmo_type (VA/VV)
- key vitals and labs

---

## 5. STANDARDS & COMPLIANCE

### 5.1 Data Standards
- **ELSO Registry v3.4**: Field definitions and terminology
- **FHIR R4**: Healthcare data interoperability
- **SMART on FHIR**: EHR app integration

### 5.2 Regulatory Standards
- **FDA Non-Device CDS Principles**:
  - Advice ≠ orders (recommendations only)
  - Show logic and inputs (transparency)
  - Clinician independent review required
- **IMDRF SaMD**: Software as Medical Device framework
- **IEC 62304**: Medical device software lifecycle
- **ISO 14971**: Risk management for medical devices

### 5.3 Clinical Coding Standards
- **ICD-10-CM**: Diagnosis codes
- **ICD-10-PCS**: Procedure codes (inpatient)
- **CPT**: Procedure codes (outpatient)
- **SNOMED-CT**: Clinical terminology

### 5.4 Compliance Principles
- Research/Education use only (not clinical deployment)
- Advice recommendations, not orders
- Full transparency of logic and inputs
- Clinician retains independent judgment

---

## 6. EXPECTED OUTCOMES

### 6.1 Academic Contributions
- **Journal Papers**: 3-5 high-impact publications
- **Conference Papers**: 5-8 international presentations
- **Open Source**: Code and datasets released publicly

**Target Journals:**
- Critical Care Medicine
- JAMA Network Open
- Intensive Care Medicine
- Journal of Medical Internet Research

### 6.2 Clinical Value
- **Survival Improvement**: 5-10% increase
- **Complication Reduction**: 15-20% decrease
- **Cost Reduction**: 10-15% savings
- **Resource Optimization**: 20-30% efficiency gains

### 6.3 International Collaboration
- Data sharing agreement with ELSO
- Participation in international ECMO research networks
- Asia-Pacific ECMO standardization initiatives

---

## 7. RISK MANAGEMENT

### 7.1 Technical Risks

| Risk | Mitigation Strategy |
|------|---------------------|
| Data quality issues | Strict data validation mechanisms |
| Model generalization | Multi-center validation, continuous learning |
| System integration challenges | Microservices architecture, standard APIs |
| Data drift | Continuous monitoring, periodic retraining |

### 7.2 Clinical Risks

| Risk | Mitigation Strategy |
|------|---------------------|
| Low physician acceptance | Enhanced training, gradual deployment |
| Regulatory approval delays | Early communication with health authorities |
| Patient privacy concerns | Strict compliance with data protection laws |
| Alert fatigue | Threshold optimization, severity stratification |

---

## 8. RESOURCE REQUIREMENTS

### 8.1 Personnel (10-14 FTE)
- Senior AI Researchers: 2-3
- Clinical Consultants: 2-3
- Software Engineers: 3-4
- Data Scientists: 2-3
- Project Manager: 1

### 8.2 Technical Resources
- **Compute**: GPU cluster for model training (cloud or on-premise)
- **Storage**: Secure medical data storage (encrypted, HIPAA-compliant)
- **Software**: Development tools, database licenses

### 8.3 Budget Estimate
- **Total**: NTD 8-12 million (USD ~260k-390k)
- **Breakdown**:
  - Personnel: 60%
  - Equipment: 20%
  - Other (software, travel, publication): 20%

---

## 9. PRIVACY & SECURITY

### 9.1 Data Protection
- **De-identification**: HIPAA-compliant anonymization
- **Encryption**: AES-256 for data at rest, TLS 1.3 for transit
- **Access Control**: Role-based authentication (RBAC)
- **Audit Logging**: Complete activity tracking

### 9.2 Compliance
- Taiwan Personal Data Protection Act
- HIPAA (for US data)
- GDPR (for EU data if applicable)

---

## 10. MODEL EXPLAINABILITY

### 10.1 Techniques
- **SHAP** (SHapley Additive exPlanations): Global feature importance
- **LIME** (Local Interpretable Model-agnostic Explanations): Local predictions
- **Attention Visualization**: Deep learning attention mechanisms
- **Clinical Narratives**: Natural language generation for explanations

### 10.2 Transparency Requirements
- Input data clearly displayed
- Model predictions with confidence intervals
- Feature contributions visualized
- Recommendation rationale in plain language

---

## 11. MODEL PERFORMANCE BENCHMARKS

### 11.1 Comparison Systems

| System | Type | Reported AUC |
|--------|------|-------------|
| APACHE II | General ICU | 0.68-0.72 |
| SAPS-3 | General ICU | 0.66-0.70 |
| SAVE score | ECMO-specific | Varies |
| RESP score | ECMO-specific (VV) | 0.74-0.78 |

### 11.2 Target Performance
- **Survival Prediction AUC**: ≥0.75
- **Validation**: 5-fold cross-validation
- **External Validation**: Taiwan medical centers (n=1000)
- **Calibration**: Hosmer-Lemeshow, calibration plots

---

## 12. CONTINUOUS LEARNING MECHANISMS

### 12.1 Monitoring
- Model performance drift detection
- Data distribution shift monitoring
- Prediction accuracy tracking
- Calibration maintenance

### 12.2 Update Strategy
- Quarterly model retraining
- Annual major version updates
- Continuous data ingestion pipeline
- A/B testing for model versions

---

## 13. PROJECT KEYWORDS

**Primary**: ecmo, critical-care, cdss, clinical-ml, explainable-ai

**Data**: mimic-iv, elso, anzics, fhir, smart-on-fhir

**Methods**: cost-effectiveness, qaly, vr-simulation

**Scope**: open-science, taiwan, health-it

---

## 14. FILE LOCATIONS

### Documentation
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\docs\ecmo_claude_code_guide.md` (202 lines)
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\docs\ecmo_core_components.csv`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\docs\ecmo_development_phases.csv`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\docs\ecmo_research_directions.csv`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\docs\comprehensive_analysis.json` (NEW)

### Prompts (Work Package Instructions)
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\WP0_data_dictionary.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\WP1_nirs_model.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\WP2_cost_effectiveness.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\WP3_vr_study.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\WP4_smart_on_fhir_stub.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\prompts\SQL_identify_ecmo.md`

### Project Root
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\README.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\CLAUDE.md` (378 lines - Agent configuration)
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\GOVERNANCE.md`
- `C:\Users\thc1006\Desktop\dev\TAIWAN-ECMO-CDSS-NEXT\TOPICS.md`

### Implementation Directories
- `etl/` - ELSO mapping and data extraction
- `sql/` - MIMIC-IV ECMO identification queries
- `nirs/` - NIRS+EHR risk models
- `econ/` - Cost-effectiveness analytics, Streamlit dashboard
- `vr-training/` - VR study protocol and metrics

---

## 15. NEXT STEPS (Implementation Priority)

### Immediate (Week 1-2)
1. **WP0**: Complete `data_dictionary.yaml` with ELSO v3.4 alignment
2. **SQL Task**: Run MIMIC-IV ECMO identification scripts
3. Set up development environment (`requirements.txt`)

### Short-term (Month 1)
4. **WP1**: Begin NIRS feature engineering (`nirs/features.py`)
5. **WP2**: Set up cost-effectiveness framework structure
6. **ETL**: Implement ELSO mapper (`etl/elso_mapper.py`)

### Medium-term (Months 2-3)
7. **WP1**: Train VA/VV models with calibration
8. **WP2**: Develop Markov model and CEAC analysis
9. **WP3**: Draft VR study protocol

### Long-term (Months 4-6)
10. **WP4**: SMART on FHIR stub implementation
11. External validation preparation
12. Dashboard deployment (`streamlit run econ/dashboard.py`)

---

## APPENDIX: Agent Coordination

This analysis was conducted using the **researcher agent** role as specified in `CLAUDE.md`:

**Coordination Memory Keys:**
- `analysis/documentation/comprehensive` - Full analysis stored
- `swarm/researcher/status` - Agent status tracking
- `swarm/shared/research-findings` - Shared findings for team

**Agent Hooks Used:**
```bash
npx claude-flow@alpha hooks pre-task --description "Comprehensive documentation analysis"
npx claude-flow@alpha hooks post-edit --file "docs/comprehensive_analysis.json"
npx claude-flow@alpha hooks post-task --task-id "documentation-inventory"
```

---

**Analysis Completed**: 2025-09-30
**Researcher Agent**: Claude Code (Sonnet 4.5)
**Memory Stored**: `coordination/analysis/documentation/comprehensive`